OpenLegislation

Division 2

United Kingdom

Original text. Later amendments are not shown.

The detection of antibodies against the ASF virus in serum or plasma exudates from organs submitted is carried out to assist the diagnosis of ASF in suspected holdings, to estimate the date of introduction of the infection in case of a confirmed outbreak and for monitoring and surveillance purposes.

The location of seropositive pigs on the holding can provide valuable information on how and where the ASF virus entered the holding.

However, an accurate evaluation of the results of the serological tests must be carried out, taking into account all the clinical, virological and epidemiological findings, in the framework of the enquiry to be carried out in case of suspicion or confirmation of ASF, in accordance with Article 8 of Directive 2002/60/EC.

Notes on Chapter VII

Textual amendments

F1

Words in Annex Ch. 7 s. B omitted (31.12.2020) by virtue of The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 8(8)(a); 2020 c. 1, Sch. 5 para. 1(1)

F2

Words in Annex Ch. 7 s. B substituted (31.12.2020) by The Exotic Disease (Amendment etc.) (EU Exit) Regulations 2018 (S.I. 2018/1410), regs. 1, 8(8)(b); 2020 c. 1, Sch. 5 para. 1(1)